tirzepatide cause depression not linked to increased risk for Psychiatric adverse events associated with

Setmelanotide (Imcivree) received FDA approval in 2020 for chronic weight management in obesity caused by genetic defects and did not result in obvious undesirable cardiovascular effects

With proper treatment, MG symptoms can be well controlled, allowing myasthenia gravis patients to have active lives

Slower dose escalation, combined with concurrent nutritional counseling and exercise programming, can reduce the rate of bone loss while still delivering meaningful weight reduction

10 Psychotropics can affect the amount of saliva secreted and may alter the composition of saliva via their receptor affects on the dual sympathetic and parasympathetic innervations of the salivary glands